GLP-1 drugs like Ozempic and Wegovy may help reduce the risk of cardiovascular disease and prevent more than 34,000 heart ...
If you’ve found yourself unexpectedly humming the tune “Magic” lately, you’re not alone. Thanks to the catchy commercial for ...
A systematic review reveals that GLP-1 receptor agonists may help reduce certain substance use disorders, but findings are ...
GLP-1 receptor agonist use was associated with a reduced risk of progressing to cirrhosis and related complications in ...
The new Lemme GLP-1 Daily Capsules are being called an "Ozempic alternative." But do they really work — and if so, at what ...
Whether positive or negative, your mood may feel different on GLP-1 medications. Researchers share why that might be and how ...
A study led by Prof. ZHU Yingjie from the Shenzhen Institute of Advanced Technology revealed that neurons in the lateral ...
The FDA said this after conducting a preliminary evaluation earlier this year of the drug class following some reports of suicidality and self-harm with GLP-1 agonists, but didn't find evidence ...
Terns Pharmaceuticals’ decision to drop its liver disease ambitions may yet pay off, after the biotech posted phase 1 data ...
A Cleveland Clinic study showed that in patients with type 2 diabetes, obesity, and chronic kidney disease, bariatric surgery ...